Another longitudinal study conducted on 132 Crohn’s disease patients identified that SNPs including TLR2 g.153688371T>C(rs1816702) and TLR2 c.597T>C (rs3804099) were linked with long-term response to Infliximab, whereas IL6 c.6331T>C (rs10499563) correlated with supratherapeutic and infratherapeutic Infliximab levels (117). Here, TLR2 is linked to Crohn disease.